Mechanism-based Choice of Therapy for Pain: Can Successful Prevention of Migraine be Coupled to a Psychophysical Pain Modulation Profile?
- Registration Number
- NCT01161017
- Lead Sponsor
- Rambam Health Care Campus
- Brief Summary
Mechanism-based choice of therapy for pain:
Can successful prevention of migraine be coupled to a psychophysical pain modulation profile?
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 67
Inclusion Criteria
- female and male migraine patients with a number of month attacks ≥ 4,
- age 18-75,
- without any other chronic pain.
Exclusion Criteria
- any migraine preventive treatment for last 6 month & psychiatric,
- language or cognitive dysfunction precluding use of psychophysics.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description 1 Amitriptyline. Amitriptyline Amitriptyline 2 Topiramate Topiramate Topiramate
- Primary Outcome Measures
Name Time Method Therapeutic response to the analgesic drugs 2 months
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie Amitriptyline and Topiramate's efficacy in migraine prevention?
How does the pain modulation profile correlate with treatment outcomes in NCT01161017?
Are there specific biomarkers that predict response to Amitriptyline or Topiramate in migraine patients?
What are the comparative adverse event profiles of Amitriptyline and Topiramate for migraine prevention?
How do combination therapies involving Amitriptyline and Topiramate compare to monotherapies in migraine management?
Trial Locations
- Locations (1)
Rambam Medical Center
🇮🇱Haifa, Israel
Rambam Medical Center🇮🇱Haifa, Israel